The market could potentially see the emergence of new biotech industry leaders. Since the year started, Viking Therapeutics (NASDAQ: VKTX) and Summit Therapeutics (NASDAQ: SMMT), two clinical-stage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results